Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Most patients with polycythemia vera (PV) and half of essential thrombocythemia (ET) possess an activating JAK2V617F mutation. The objective of this study was to better define the effect of JAK2V617F mutant allele burden on clinical phenotypes in Chinese patients, especially thrombosis. | Impact of JAK2V617F mutation burden on disease phenotype in Chinese patients with JAK2V617F-positive Polycythemia vera (PV) and Essential thrombocythemia (ET)